Equillium EQ
NASDAQ EQ
$1.54 -0.09 (-5.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Equillium (EQ) Non-Current Deffered Revenue (2022 - 2023)

Updated

Equillium (EQ) reported Non-Current Deffered Revenue of $2.42 million for Q3 2023, down 59.4% from the prior quarter.

Analysis

Equillium (EQ) Non-Current Deffered Revenue (2022 - 2023) Analysis & Trends

At the end of FY2022, Equillium posted Non-Current Deffered Revenue of $10.38 million.

  • Per Business Quant data, the three quarters before Q3 2023 came in at $5.96 million (Q2 2023), $7.94 million (Q1 2023) and $10.38 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Equillium 181.13 Mn 181.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2.42 Mn
Jun 30, 2023 5.96 Mn
Mar 31, 2023 7.94 Mn
Dec 31, 2022 10.38 Mn
API Access

Equillium Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EQ&period=max&api_key=YOUR_API_KEY